South Africa halts Johnson & Johnson vaccine jabs; Europe rollout delayed

South Africa suspended giving Johnson & Johnson vaccine shots Tuesday as a "precautionary measure" and the company delayed its European vaccine rollout following the FDA decision to pause using the jabs while very rare blood clot cases are examined. South Africa has given more than 289,000 jabs of the J&J vaccine to the country's health workers without any reports of blood clots, Health Minister Dr. Zweli Mkhize told reporters. He said South Africa was halting the use of J&J jabs "out of an abundance of caution" and he expects that the questions over the J&J vaccine should "be cleared within a matter of days.”

South Africa suspended giving Johnson & Johnson vaccine shots Tuesday as a "precautionary measure" and the company delayed its European vaccine rollout following the FDA decision to pause using the jabs while very rare blood clot cases are examined. South Africa has given more than 289,000 jabs of the J&J vaccine to the country's health workers without any reports of blood clots, Health Minister Dr. Zweli Mkhize told reporters. He said South Africa was halting the use of J&J jabs "out of an abundance of caution" and he expects that the questions over the J&J vaccine should "be cleared within a matter of days.” April 14, 2021 at 06:42AM https://ift.tt/3wTFHJq